Karyopharm Therapeutics Announces ASH 2026 Clinical Trial Presentations

Article summary

Karyopharm Therapeutics announced that abstracts for clinical trials evaluating selinexor in myelofibrosis and multiple myeloma have been selected for presentation at the 2026 American Society of Hematology (ASH) annual meeting.